We have evaluated a new commercially available enzyme-linked immunorsorbant assay for neopterin :or its suitability in the context of screening of voluntary blood donors. The assay was performed on 1040 consecutive blood donors, and compared with radioimmunoassay and. in a fraction of 142 donors . . : Iso with high performance liquid chromatography. On repetitive assays of all donations showing a concentration exceeding 8.0 nmol/L in the initial assay. three of the radioimmunoassay results were identified as gross outliers. No such gross outliers were detected for the enzyme-linked immunosorbant assay. RegarJing the reproducibility of results exceeding a cut-off limit of \0 nmol/L neopterin. the enzyme-linked ;mmunosorbant assay was better than the radioimmunoassay. Moreover. the enzyme-linked immunosorbant assay was slightly superior to radioimmunoassay when both tests were compared with high performance liquid chromatography (based on linear regression analysis. evaluation of frequencies of concentrations bant assay was slightly superior to radioimmunoassay when both tests were compared with high performance liquid chromatography (based on linea r regression analysis. evaluation of frequencies of concentrations rations. Its slight superiority compared to the conventional radioimmunoassay likely results from the higher degree of automatization employed.
Introduction
6-D-erythro-Neopterin is synthesized in significantly elevated amounts by human macrophages upon activation by Y-interferol1 (I) . Therefore. its concentrations in various body fluids reflect degree of endogenous production of Y-interferon and costimulatory cytokines such as tumor necrosis factor-C!. Neopterin is metabolically stable. and its concentrations can be conveniently measured; therefore. it has been §To whom correspondence and requests for reprints should be addressed Ptcridines / Vol. 5 / No.2 used as marker for ceIIular immune activation 111 various diseases (2) (3) (4) (5) .
Measurement of neoptelin concentrations is possible by high performance liquid chromatography (HPLC). or by radioimmunoassay (RIA) techniques (6) (7) (8) (9) . More recently. enzyme-linked immunosorbant assay (ELISA) techniques were described for detection of neopterin (10) (11) (12) (13) (14) (15) .
One important application of neopterin testing has emerged in the field of transfusion medicine: neopterin elevations are a sensitive and early sign for acute and chronic infections by a broad spect-rum of potentially hazardous pathogens. Thus, neopterin measurement can be used to screen blood donors for presence of infections in a global sense, In addition to specific serological tests. Moreover. In many non-infectious diseases which also are to be excluded from blood donation such as, eg .. autoimmune disorders or cancer, neopterin concentrations are frequently elevated. Therefore, in the Austrian Tyrol neopterin is screened for routinely in each blood sample donated by voluntary blood donors since 1986, with the rationale of providing improved safety for the recipient of blood donations (16 A brief summary of the findings reported here was also published elsewhere (17) .
Materials and Methods

Serum samples
Samples were drawn from 1040 consecutive apparently healthy volunteers donating blood within the frame of regular blood donation actions of the Red Cross Blood Donation Service of TyroL Austria. during one week in spring of 1993. The blood was routinely investigated at the Central Institute for Blood Transfusion and Immunology of the University Hospital at Innsbruck. Each donor had passed the routine physical examination by the responsible physician, and had denied questions regarding his or her suffering from acute or chronic diseases.
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Methods
Since its initiation In 1986, the following protocol has been employed for routine testing of neopterin in blood donations by RIA: if a specimen in an initial analysis shows a neopterin concentration exceeding 10 nmol/L (this concentration is used as upper limit of normal; it represents approximately the 98th percentile of neopterin concentrations in blood of healthy adults between 18 and 76 years). two further neopterin determinations are performed on the same sample. If by taking the mean value of these two additional tests the raised neopterin concentrations is confirmed. the respective donation is withdrawn and not used for transfusion purposes. This protocol was used in the present study with one exception: two confirmatory repetitions of the analysis were performed even when the initial result exceeded 8.0 nmol/L. in order to provide a broader data basis for statistical analysis of the results.
RIA was done by a commercially available assay kit (Immutest. Henning-Berlin. Berlin. Germany). The correlation between RIA and HPLC had been investigated and described earlier (9) .
ELISA measurements were performed by a newly developed commercially available assay kit (ELI test, Henning-Berlin) which was developed with the specific goal to provide an accurate means of neopterin detection in the context of donated blood. Notably. earlier generations of the assay as well as comparable ELISAs by other companies showed too high a frequency of elevated neopterin results when tested on very fresh blood samples, particularly in the field of transfusion medicine (data not shown here).
Following the prescriptions of the manufacturer, this assay was performed on each of the 1040 donor sera. using the same protocol as reported above for the RIA measurements. In particular. two additional repetitions of the assay were done if the initial result
In a fraction of those blood donations which undelwent repeated assays as described. there was serum available for additional neopterin determination by HPLC. This was done by a previously described (9) procedure using reversed-phase HPLC with online deproteinization of samples.
Statistical evaluation
The data obtained by the various analytical techniques were compared by linear regression and correlation technique. In addition. You den indices (= sensitivity + specificity -)) were determined for ELISA and RIA results whereby the required c1assi-fication of individuals was performed on the basis of HPLC results.
Results
Performance characteristics oj the EUSA
Intra-assay precision was determined using eight different sera with mean neopterin concentrations ranging from 4.8 to 37.6 nmol/L. On each of these s~ra, five determinations were done on the same 96-well plate, yielding individual coefficients of variation ranging from 1.47 to 9.07% with a median ,)1' 5.09%. Inter-assay precision was evaluated using eight different sera with mean neopterin concentrations ranging from 4.7 to 31.0 nmol/L. Each serum \\a5 analyzed on five different 96-well plates, yielJing individual coefficients of variation ranging from 3.03 to 10.14% with a median of 6.54%. On three sera with neopterin concentrations of 31.1, 3.3 dnd 40.1 nmol/ L, dilution experiments were performed: each serum was diluted in three steps with halving the concentrations by each step. The percentages of measured versus expected neopterin concentrations were detelmined; values ranged from 92.2 to 106.7%, the individual median values were 101.5%, 96.2%, and 99.8%, respectively. Table 1 shows the results obtained by ELISA and RIA on sera from 1040 apparently healthy blood donors. The mean value obtained by ELISA agreed better than RIA data with mean values obtained previously by RIA on more than 76000 blood donors (16) . The mean value obtained by RIA remained higher (by about 1 nmol/L) even after eliminating three donors from the data set for whom values exceeding 50 nmol/L were obtained by RIA (these were gross outliers according to the repetitive analyses as well as to measurement by HPLC). Figure I shows the ELISA results obtained versus the RIA results; three outliers by RIA are not included in the figure (see legend). The results of linear regression analyses, based on these data, are summarized in Table 2 . Not surprisingly, the three extreme outliers had a disastrous effect on the linear regression (all 1040 data pairs included); only after elimination of these outliers reasonable values were obtained for the regression coefficient (which ideally should be 1.(00), the intercept (ideal value 0.(00) and the linear correlation coefficient (ideal value 1.(00). only by RIA and 10, only by ELISA.
Initial results
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Reperiril'e analyses
There were 152 cases on whom two further ELISA tests were made, including the 42 cases with neopterin above 10.0 nmol/ L in the initial assay. Linear regression analysis of the mean values of the two repetitions on the initial assay results yielded a regression coefficient of 0.77 (SE 0.026) and a linear correlation coefficient of 0.927. In 29 of the 42 (69.0 %) donors having shown raised neopterin in the initial assay, the mean value of the two repetitions remained above 10.0 nmol/L, and in 1 of the 110 donors (0.9%) who had neopterin below 10.0 nmol in the initial assay, a value above this cut-off was found by the repetitive assays.
Similarly, there were 227 cases on whom two further RIA tests were made, including the 63 cases with neopterin above 10.0 nmol/L in the initial assay. Linear regression analysis of the mean values of the two repetition on the initial assay results yielded a regression coefficient of 0.902 (SE 0.037) and a linear correlation coefficient of 0.855. In 33 of the 63 (52.4%) donors having shown raised neopterin in the initial assay, the mean value of the two repetitions remained above 10.0 nmol/L, and in 14 of the 164 donors (8.5%) who had neopterin below 10.0 nmol in the initial assay, a value above this cut-off was found by the repetitive assays.
Repetitive assays were made for ELISA as well as for RIA on 119 donors: 70 were found below the cut-off limit in both assays. 24 were ahove the cut-off limit in both assays, 21 were ele\ated only Pteridines / Vol. 5 / No. 2 by RIA and 4, only by ELISA. Linear regression analysis of these data (dependent variable: mean value of repetitive assays by ELISA; independent variable: mean value of repetitive assays by RIA) yieloded a regression coefficient of 1.016 (SE 0.063) and a linear correlation coefficient of 0.830.
HPLC results
Among those donors for whom analyses were done repetitively for ELISA and/or RIA there were 142 on whom also HPLC results could be obtained. Table 3 shows results of linear regression analyses, whereby HPLC results were chosen as independent variable, and either ELISA or RIA results of the initial analysis were taken as dependent variable.
(Note that for analysis of RIA data, one outlier with a RIA value above 50 nmol/L was eliminated). Interestingly, the linear correlation coefficient was slightly better for RIA but the regression coefficient as well as the intercept were better for the ELISA data.
Of these 142 donors, 116 had a neopterin concentration below 10.0 nmol/L by HPLC and 26 had a value ahove this limit. Of the 116 cases with low HPLC data, 105 (90.5%) had low ELISA neopterin, but only 99 (85.3%) had low RIA neopterin. Of the 26 donors with high neopterin by HPLC there were 23 (88.5%) with high ELISA results, and 22 (84.6%) with high RIA results.
There were 109 donors on whom repetitive results were available for ELISA as well as for RIA. and also HPLC data. The results comparing these repe-tltlve data with HPLC were similar as those above: 84 donors had neopterin below 10.0 nrnol/L by HPLC. and 25 had a raised value. 82 of 84 (97.6%) had low ELISA results, but only 69/84 (82.1%) of RIA results agreed with HPLC analysis. On the other hand, RIA was slightly more sensitive than ELISA: 22/25 (88.0%) versus 19/25 (76.0%).
Finally, Youden index curves were constructed for these 109 donors. Here HPLC results were considered as "golden standard", i.e., donors were classified accord ing to HPLC neopteri n below and up to, versus above 10 nmol/L. The Youden index curves were then computed on this categorization, both for initial RIA and ELISA results. Figure 2 demonstrates that in agreement with all other analyses. ELISA Jata performed slightly better than RIA data.
Discussion
Development of an accurate and sensiti ve ELISA fo r neopterin in serum has become a stringent reljuirement in Austria because of the fact that all .-\ustrian blood banking institutions have received an order by the Federal Government %0 include into the panel of laboratory tests for donated blood an assay to detect activation of cellular immunity. Several ELISAs were developed during recent years (10) (11) (12) (13) (14) (15) . We have evaluated a new ELISA and by comparison with the well-established RIA and HPLC procedures have found that this test is at least as suitable as the RIA technique which has heen used hitherto in the field of screening blood donations for neopterin concentration.
This conclusion has been arrived at by different statistical routes. First. ELISA results in our study did not exhibit gross outliers. but RIA did (3 cases out of 1040). Second. frequency of neopterin concentrations exceeding 10 nmol/L was higher for RIA than for ELISA in the initial analysis, but on repetitive assays, 138 out of 152 (90.8%) ELISA results were confirmed, but only 183 out of 227 (80.6%) RIA results, when using the 10 nmol/L criterion for judgement. Similarly, 128 of 142 (90.1 %) cases in whom HPLC was done had a correct ELISA result in the initial analysis, but only 121 of 142 (85.2%) had a RIA result correspond ing with HPLC data. Analogously. linear regression and correlation data were generally more favorab le for ELISA th an for RIA. And finally, Youden index analysis based on HPLC data revealed a slight sllperiority for ELISA over RIA.
Clearly, none of these a nalytical procedures is perfect. But summarizing all the \.?\idences presented above. the statement concerning the suitabili ty of the new ELISA seems to be Justified. The most likely reason for the slight superiority of ELISA over RIA is, in our opinion, the better automatizatio n of the latter. allowing for reduction of pipetting errors and th e like. A most important feature of this new technique is the apparent absence of analytical problems with fresh sera. In none of the investigated samples th ere was evidence for such a problem while there were at least three dramatic outliers fOll nd by RIA. Neopterin measurement has become compulsory in blood banking in Austria. The rationale for this additional assay is the reduction of hazards to transfusion reCIpIents by infectious contamination of donated blood. According to our results. the new ELISA for neopterin evaluated in this study seems to be suitable for its application in the context of transfusion medicine where the primary goal is to differentiate between neopterin concentrations below versus above a cut-off limit of \0 nmol/L. Its analytical properties are at least as good as those of the usually employed RIA technique, the practical convenience of the test is superior to RIA, and the absence of radioactive materials is an additional most desirable feature.
